$75.00
10mg – Lyophilized *MUST BE RECONSTITUTED*
Introducing DSIP – a neuropeptide that has been extensively studied for its influence on various endocrine and physiological processes within the central nervous system. Research suggests that DSIP can reduce oxidative stress, normalize myocardial contractility, and is being explored as a potential target for the treatment of major depressive disorder. Ideal for research applications, DSIP offers a promising avenue for investigating advanced therapeutic solutions and enhancing our understanding of central nervous system functions.
DSIP 10mg (Delta Sleep-Inducing Peptide) is a premium, high-purity synthetic nonapeptide designed to study slow-wave sleep cycles, neuroendocrine HPA axis regulation, and central nervous system stress adaptation. By modulating critical neurotransmitter pathways and reducing oxidative stress markers, this 10mg formulation serves as an advanced investigative tool for tracking circadian rhythm stabilization, neural protection, and homeostatic recovery in laboratory models.
Supplied as a stable, premium-grade lyophilized powder in a 10mg vial. *MUST BE RECONSTITUTED FOR RESEARCH APPLICATIONS.* Restricted strictly to laboratory and in vitro evaluation.
Eterna Peptides presents premium-grade DSIP (10mg) lyophilized powder, a highly purified synthetic neuromodulating nonapeptide. Universally recognized as Delta Sleep-Inducing Peptide, DSIP is extensively evaluated in neurological and endocrine research to study the induction of slow-wave sleep cycles, central nervous system stress adaptation, and systemic homoeostatic regulation.
Mechanism of Action
DSIP is a unique, naturally occurring regulatory peptide that crosses the blood-brain barrier to interface with complex central signaling networks:
* **Sleep Architecture Modulation:** Research indicates DSIP interacts directly with GABAergic, glutamatergic, and serotonergic pathways to promote and stabilize delta (slow-wave) sleep patterns without causing sedative dependency or altering normal waking behavior.
* **Neuroendocrine Regulation:** It acts as an upstream modulator within the hypothalamic-pituitary-adrenal (HPA) axis, helping track the suppression of acute corticotropin-releasing hormone (CRH) and cortisol spikes during stress modeling.
* **Oxidative Stress Mitigation:** In vitro studies demonstrate its capacity to scavenge free radicals, upregulate antioxidant enzyme activity, and protect neuronal cell matrices from metabolic trauma.
* **Myocardial Protection:** Advanced physiological profiles suggest DSIP may assist in normalizing myocardial contractility and balancing blood pressure fluctuations under severe environmental stressors.
Research Applications
In preclinical and in vitro laboratory models, DSIP 10mg is actively utilized to investigate:
* Structural sleep cycle optimization, deep sleep latency tracking, and circadian rhythm restoration.
* The mitigation of chronic stress responses, anxiety-induced signaling, and major depressive disorder pathways.
* Neuroprotective shielding, cellular longevity, and central nervous system cellular integrity.
* LH (luteinizing hormone) and GH (growth hormone) pulsatility modulation via somatotrophic signaling.
Our DSIP vials undergo strict laboratory quality control guidelines to ensure absolute compound purity, structural integrity, and exceptional analytical consistency across all research setups.
—
*Disclaimer: This product is sold strictly for laboratory research and development use only. It is not intended for human consumption, diagnostic, or therapeutic purposes.*
